Immune signatures predictive of optimal cytoreduction in ovarian cancer

被引:0
|
作者
Simons, E. [1 ]
Kiet, T. [1 ]
Amanam, I. [1 ]
Ho, M. [1 ]
Fuh, J. [1 ]
Fuh, K. [1 ]
Kapp, D. [2 ]
Odunsi, K. [3 ]
Chan, J. [1 ]
机构
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
D O I
10.1016/j.ygyno.2011.12.108
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
107
引用
收藏
页码:S46 / S46
页数:1
相关论文
共 50 条
  • [41] Optimal cytoreduction in stage IV ovarian carcinoma -: In reply
    Bonnefoi, H
    Gore, ME
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 3004 - 3004
  • [42] Immune biomarkers predictive of survival in epithelial ovarian cancer
    Simons, E.
    Kiet, T.
    Amanam, I.
    Ho, M.
    Fuh, J.
    Fuh, K.
    Kapp, D.
    Odunsi, K.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S45 - S46
  • [43] Predictive radiological score MRI-difussion sequence of complete surgical cytoreduction in ovarian cancer
    Sainz de La Cuesta, Ricardo
    Iacoponi, Sara
    Jimenez, Mar
    Hernandez Cortes, Gines
    Rubio, Margarita
    Alvarez, Elena
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S133 - S134
  • [44] Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer
    Vanderstichele, Adriaan
    Busschaert, Pieter
    Olbrecht, Siel
    Lambrechts, Diether
    Vergote, Ignace
    EUROPEAN JOURNAL OF CANCER, 2017, 86 : 5 - 14
  • [45] Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
    Coleman, Robert L.
    Spirtos, Nick M.
    Enserro, Danielle
    Herzog, Thomas J.
    Sabbatini, Paul
    Armstrong, Deborah K.
    Kim, Jae-Weon
    Park, Sang-Yoon
    Kim, Byoung-Gie
    Nam, Joo-Hyun
    Fujiwara, Keiichi
    Walker, Joan L.
    Casey, Ann C.
    Alvarez Secord, Angeles
    Rubin, Steve
    Chan, John K.
    DiSilvestro, Paul
    Davidson, Susan A.
    Cohn, David E.
    Tewari, Krishnansu S.
    Basen-Engquist, Karen
    Huang, Helen Q.
    Brady, Mark F.
    Mannel, Robert S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (20): : 1929 - 1939
  • [46] Tertiary cytoreduction in the setting of recurrent ovarian cancer
    Dogan, Nasuh Utku
    Schneider, Achim
    Chiantera, Vito
    Dogan, Selen
    Dursun, Polat
    ONCOLOGY LETTERS, 2013, 6 (03) : 642 - 647
  • [47] Secondary cytoreduction for patients with recurrent ovarian cancer
    Díaz-Montes T.P.
    Bristow R.E.
    Current Oncology Reports, 2005, 7 (6) : 451 - 458
  • [48] Laparoscopic Cytoreduction for Primary Advanced Ovarian Cancer
    Fanning, James
    Hojat, Rod
    Johnson, Jil
    Fenton, Bradford
    JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS, 2010, 14 (01) : 80 - 82
  • [49] Beyond Quaternary Cytoreduction for Recurrent Ovarian Cancer
    Bodog, Alin
    Bacalbasa, Nicolae
    Balescu, Irina
    Dima, Simona
    Suciu, Ionut
    Ionescu, Olivia
    Suciu, Nicolae
    Tomescu, Dana
    PROCEEDINGS OF THE 4TH CONGRESS OF THE ROMANIAN SOCIETY FOR MINIMAL INVASIVE SURGERY IN GINECOLOGY / ANNUAL DAYS OF THE NATIONAL INSTITUTE FOR MOTHER AND CHILD HEALTH ALESSANDRESCU-RUSESCU, 2019, : 55 - 59
  • [50] Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
    Coleman, Robert L.
    Spirtos, Nick M.
    Enserro, Danielle
    Herzog, Thomas J.
    Sabbatini, Paul
    Armstrong, Deborah K.
    Kim, Jae-Weon
    Park, Sang-Yoon
    Kim, Byoung-Gie
    Nam, Joo-Hyun
    Fujiwara, Keiichi
    Walker, Joan L.
    Casey, Ann C.
    Secord, Angeles Alvarez
    Rubin, Steve
    Chan, John K.
    DiSilvestro, Paul
    Davidson, Susan A.
    Cohn, David E.
    Tewari, Krishnansu S.
    Basen-Engquist, Karen
    Huang, Helen Q.
    Brady, Mark F.
    Mannel, Robert S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2020, 75 (03) : 165 - 166